Dogecoin Cash, Inc. (DOGP) Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" — a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain — and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.
Sector: Services-Personal Services
Industry: Medical - Healthcare Information Services
Dogecoin Cash, Inc. OTC:DOGP Healthcare · Medical - Healthcare Information Services
All Press Release SEC Filings News
SEC Filing ● Major ⚠ 9
DOGP: 10-Q · periodic report
Dogecoin Cash, Inc. filed its 10-Q for the quarter ended June 30, 2026, reporting Q2 revenue of $166,511, down 13% year over year, which management attributed to intensifying competition in the cannabis tele-medicine industry.
The company posted a Q2 net loss of $137,706 and a six-month net loss of $338,176, ending the quarter with only $10,971 in cash against $903,960 in current liabilities and an accumulated deficit of $84.7 million.
Management disclosed substantial doubt about the company's ability to continue as a going concern, stated that cash on hand does not cover immediate operating needs, and concluded that disclosure controls and procedures were not effective due to material weaknesses.
Beyond its PrestoDoctor telehealth business, the company holds approximately 8.02 billion Dogecoin Cash ($DOG) tokens through subsidiaries, and warned that any future equity or convertible-debt raise would dilute current shareholders.
SEC 10-Q • 2mo ago AI analysis › SEC Filing ⚠ 4
DOGP: NT 10-Q · late filing
Dogecoin Cash, Inc. filed a Form 12b-25 (NT 10-Q) on August 12, 2026, notifying the SEC that it could not file its Form 10-Q for the quarter ended June 30, 2026 by the prescribed deadline.
The company said it requires additional time to finalize the quarterly report in coordination with its independent registered public accounting firm and expects to file within the Rule 12b-25 extension period, which allows five extra calendar days for a 10-Q. Management checked 'No' when asked whether a significant change in results of operations versus the prior-year period is anticipated.
The notification was signed by CEO David Tobias, and the cover of the filing discloses that Dogecoin Cash, Inc. was formerly known as Cannabis Sativa, Inc. A late 10-Q at a recently rebranded micro-cap is a reporting-discipline red flag worth monitoring even without disclosed going-concern or auditor issues.
SEC NT 10-Q • 2mo ago Press Release ⚠ 2
DOGECOIN CASH FILES UTILITY PATENT FOR BLOCKCHAIN INFRASTRUCTURE DESIGNED TO SUPPORT DOGECOIN APPLICATION USABILITY
Dogecoin Cash, Inc. (DOGP) announced the filing of a U.S. utility patent application (No. 19/707,268) with the USPTO.
The application covers a modular, blockchain-agnostic framework designed to improve Dogecoin transaction usability, including sub-5-second confirmation notifications and low-code deployment tools.
The company stated the filing builds upon a previously filed provisional patent and aims to address practical developer challenges in the Dogecoin ecosystem.
• 4mo ago AI analysis › SEC Filing ⚠ 7
DOGP: 10-Q · periodic report
Dogecoin Cash, Inc. reported a net loss of $200,470 for the quarter ended March 31, 2026, driven by operating expenses of $283,381 that outpaced revenue of $192,898. The company holds only $19,510 in cash, which management explicitly states is insufficient to meet immediate operational needs.
The filing includes a going-concern warning, citing an accumulated deficit of $84.5 million and dependence on future financing to continue operations. Management also disclosed material weaknesses in internal controls, attributing them to the small size of the accounting staff and lack of segregation of duties.
The company continues to hold approximately 8 billion Dogecoin Cash ($DOG) tokens as digital assets, while its primary operating subsidiary, PrestoCorp, provides telehealth referral services. A previously proposed merger with MJ Harvest, Inc. has been effectively abandoned after MJ Harvest was delisted from OTC markets.
SEC 10-Q • 5mo ago AI analysis › SEC Filing ⚠ 2
DOGP: NT 10-Q · late filing
Dogecoin Cash, Inc. (formerly known as Cannabis Sativa, Inc.) has filed a Notification of Late Filing for its Form 10-Q for the period ended March 31, 2026. The delay is due to a temporary administrative delay at the company’s operating subsidiary, which compressed the preparation timeline for the consolidated financial statements. The company’s independent registered public accounting firm did not have sufficient time to complete its required review procedures within the prescribed filing period.
The company expects to file the Form 10-Q within the five-business-day extension period provided by Rule 12b-25. CEO David Tobias has signed the notification, and the company is working diligently with its auditor to complete the required work.
SEC NT 10-Q • 5mo ago Press Release
Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification
globenewswire.com • 6mo ago